ARTICLE | Company News
Osel, Miyarisan in GI deal
March 3, 2005 3:33 AM UTC
Osel (Santa Clara, Calif.) received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM, a tablet that contains a strain of C. butyricum to treat and prevent antibiot...